John K. C. Lim
Impact in
- Molecular Biology top 10%
- DNA and Nucleic Acid Chemistry
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- RNA modifications and cancer
- RNA and protein synthesis mechanisms
- DNA Repair Mechanisms
- Ubiquitin and proteasome pathways
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
- Oncology 12
- HER2/EGFR in Cancer Research 4
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 2
-
- Ubiquitin and proteasome pathways 2
- Co-authors
- Sean O’Brien (7 shared papers)Denis Drygin (4 shared papers)William G. Rice (4 shared papers)Adam Siddiqui-Jain (4 shared papers)Caroline B. Ho (4 shared papers)Chris Proffitt (4 shared papers)Kenna Anderes (5 shared papers)Daniel D. Von Hoff (5 shared papers)
- Journals
- Molecular Cancer Therapeutics (5 papers)Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Journal of Medicinal Chemistry (2 papers)Organometallics (2 papers)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
John K. C. Lim
25 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 798
- Oncology 238
- Cancer Research 87
- Otorhinolaryngology 17
- Hematology 35
Countries citing papers authored by John K. C. Lim
This map shows the geographic impact of John K. C. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John K. C. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John K. C. Lim more than expected).
Fields of papers citing papers by John K. C. Lim
This network shows the impact of papers produced by John K. C. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John K. C. Lim. The network helps show where John K. C. Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside John K. C. Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 467 | |
| 2 | 2019 | 138 | |
| 3 | 2012 | 86 | |
| 4 | 2012 | 59 | |
| 5 | 2011 | 58 | |
| 6 | 2017 | 52 | |
| 7 | 2014 | 38 | |
| 8 | 1997 | 32 | |
| 9 | 2005 | 30 | |
| 10 | 2017 | 18 | |
| 11 | 2000 | 18 | |
| 12 | 2000 | 15 | |
| 13 | 2018 | 15 | |
| 14 | Pharmacokinetic findings from the phase I study of Quarfloxin (CX-3543): a protein-rDNA quadruplex inhibitor, in patients with advanced solid tumors. | 2007 | 10 |
| 15 | 2015 | 10 | |
| 16 | 2023 | 9 | |
| 17 | 1988 | 9 | |
| 18 | 2000 | 8 | |
| 19 | 2019 | 6 | |
| 20 | 2017 | 3 |
About John K. C. Lim
John K. C. Lim is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Genomics and Diagnostics (3 papers), Ubiquitin and proteasome pathways (2 papers), Asymmetric Hydrogenation and Catalysis (2 papers), CAR-T cell therapy research (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Molecular Biology (798 citations), Oncology (238 citations), Cancer Research (87 citations), Otorhinolaryngology (17 citations) and Hematology (35 citations). John K. C. Lim has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Sean O’Brien, Denis Drygin, William G. Rice, Adam Siddiqui-Jain, Caroline B. Ho, Chris Proffitt, Kenna Anderes, Daniel D. Von Hoff, Josh Bliesath and Michael K. Schwaebe. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Journal of Clinical Oncology, Journal of Medicinal Chemistry and Organometallics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.